What can metabolic myopathies teach us about exercise physiology?

Applied Physiology, Nutrition and Metabolism

Volumn 31, Issue 1, 2006, Pages 21-30

  Tarnopolsky, Mark A ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Inborn errors of metabolism; McArdle's disease; MELAS syndrome; Mitochondrial disease; Myoadenylate deaminase deficiency

Indexed keywords

4 AZA 4 METHYLPREGNANE 3,20 DIONE; 4-AZA-4-METHYLPREGNANE-3,20-DIONE; AZASTEROID; FATTY ACID; GLYCOGEN PHOSPHORYLASE; PREGNANEDIONE;

EXERCISE; HUMAN; METABOLIC DISORDER; METABOLISM; MITOCHONDRIAL MYOPATHY; MUSCLE CONTRACTION; MUSCLE DISEASE; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

AZASTEROIDS; EXERCISE; FATTY ACIDS; GLYCOGEN PHOSPHORYLASE, MUSCLE FORM; HUMANS; METABOLIC DISEASES; MITOCHONDRIAL MYOPATHIES; MUSCLE CONTRACTION; MUSCULAR DISEASES; OXIDATION-REDUCTION; PREGNANEDIONES;

EID: 33744987438     PISSN: 17155312     EISSN: None     Source Type: Journal    
DOI: 10.1139/h05-008     Document Type: Review

References (82)

1. Anderson, J.L., Habashi, J., Carlquist, J.F., Muhlestein, J.B., Horne, B.D., Bair, T.L., Pearson, R.R., and Hart, N. 2000. A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease. J. Am. Coll. Cardiol. 36: 1248-1252.
2. Barbiroli, B., Frassineti, C., Martinelli, P. Iotti, S., Lodi, R., Cortelli, P., and Montugna, P. 1997. Coenzyme Q10 improves mitochondrial respiration in patients with mitochondrial cytopathies. An in vivo study on brain and skeletal muscle by phosphorous magnetic resonance spectroscopy. Cell Mol. Biol. (Noisy-Le-Grand), 43: 741-749.
3. Bender, H., and Kandenbach, B. 2000. The allosteric ATP-inhibition of cytochrome c oxidase activity is reversibly switched on by cAMP-dependent phosphorylation. FEBS Lett. 466: 130-134.
4. Berbel-Garcia, A., Barbera-Farre, J.R., Etessam, J.P., Salio, A.M., Cabello, A., Gutierrez-Rivas, E., and Campos, Y. 2004. Coenzyme Q 10 improves lactic acidosis, strokelike episodes, and epilepsy in a patient with MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes). Clin. Neuropharmacol. 27: 187-191.
5. Bergstrom, J., and Hultman, E. 1967. A study of the glycogen metabolism during exercise in man. Scand. J. Clin. Lab. Invest. 19: 218-228.
6. Bergstrom, J., Hermansen, L., Hultman, E., and Saltin, B. 1967. Diet, muscle glycogen and physical performance. Acta Physiol. Scand. 71: 140-150.
7. Bernier, F.P., Boneh, A., Dennett, X., Chow, C.W., Cleary, M.A., and Thorburn, D.R. 2002. Diagnostic criteria for respiratory chain disorders in adults and children. Neurology. 59: 1406-1411.
8. Blazev, R., and Lamb, G.D. 1999. Adenosine inhibits depolarization- induced Ca(2+) release in mammalian skeletal muscle. Muscle Nerve. 22: 1674-1683.
9. Borchert, A., Wilichowski, E., and Hanefeld, F. 1999. Supplementation with creatine monohydrate in children with mitochondrial encephalomyopathies. Muscle Nerve, 22: 1299-1300.
10. Carter, S.L., Rennie, C., and Tarnopolsky, M.A. 2001. Substrate utilization during endurance exercise in men and women after endurance training. Am. J. Physiol. Endocrinol. Metab. 280: E898-E907.
11. Chance, B., and Bank, W. 1995. Genetic disease of mitochondrial function evaluated by NMR and NIR spectroscopy of skeletal tissue. Biochim. Biophys. Acta. 1271: 7-14.
12. Chen, R.S., Huang, C.C., and Chu, N.S. 1997. Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study. Eur. Neurol. 37: 212-218.
13. Dandurand, R.J., Matthews, P.M., Arnold, D.L., and Eidelman, D.H. 1995. Mitochondrial disease. Pulmonary function, exercise performance, and blood lactate levels. Chest, 108: 182-189.
14. Dawson, K.D., Howarth, K.R., Tarnopolsky, M.A., Wong, N.D., and Gibala, M.J. 2003. Short-term training attenuates muscle TCA cycle expansion during exercise in women. J. Appl. Physiol. 95: 999-1004.
15. Deschauer, M., Wieser, T., and Zierz, S. 2005. Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects. Arch. Neurol. 62: 37-41.
16. Dimauro, S., and Eastwood, A.B. 1977. Disorders of glycogen and lipid metabolism. Adv. Neurol. 17: 123-142.
17. Dimauro, S., Bonilla, E., Davidson, M., Hirano, M., and Schon, E.A. 1998. Mitochondria in neuromuscular disorders. Biochim. Biophys. Acta. 1366: 199-210.
18. Dimauro, S., Mancuso, M., and Naini, A. 2004a. Mitochondrial encephalomyopathies: therapeutic approach. Ann. N.Y. Acad. Sci. 1011: 232-245.
19. Dimauro, S., Tay, S., and Mancuso, M. 2004b. Mitochondrial encephalomyopathies: diagnostic approach. Ann. N.Y. Acad. Sci. 1011: 217-231.
20. Finsterer, J. 2003. Lactate stress testing by bedside lactate determination. Metab. Brain Dis. 18: 265-272.
21. Fischer, S., Drenckhahn, C., Wolf, C., Eschrich, K., Kellermann, S., Froster, U.G., and Schober, R. 2005. Clinical significance and neuropathology of primary MADD in C34-T and G468-T mutations of the AMPD1 gene. Clin. Neuropathol. 24: 77-85.
22. Fishbein, W.N., Armbrustmacher, V.W., and Griffin, J.L. 1978. Myoadenylate deaminase deficiency: a new disease of muscle. Science, 200: 545-548.
23. Fu, K., Hartlen, R., Johns, T., Genge, A., Karpati, G., and Shoubridge, E.A. 1996. A novel heteroplasmic tRNAleu(CUN) MtDNA point mutation in a sporadic patient with mitochondrial encephalomyopathy segregates rapidly in skeletal muscle and suggests an approach to therapy. Hum. Mol. Genet. 5: 1835-1840.
24. Fueger, P.T., Shearer, J., Krueger, T.M., Posey, K.A., Bracy, D.P., Heikkinen, S., Laakso, M., Rottman, J.N., and Wasserman, D.H. 2005. Hexokinase II protein content is a determinant of exercise endurance capacity in the mouse. J. Physiol. 566: 533-541.
25. Haller, R.G., and Vissing, J. 2002. Spontaneous "second wind" and glucose-induced second "second wind" in McArdle disease: oxidative mechanisms. Arch. Neurol. 59: 1395-1402.
26. Haller, R.G., and Vissing, J. 2004. No spontaneous second wind in muscle phosphofructokinase deficiency. Neurology. 62: 82-86.
27. Haller, R.G., Dempsey, W.B., Feit, H., Cook, J.D., and Knochel, J.P. 1983. Low muscle levels of pyridoxine in McArdle's syndrome. Am. J. Med. 74: 217-220.
28. Hanisch, F., and Zierz, S. 2003. Only transient increase of serum CoQ subset 10 during long-term CoQ10 therapy in mitochondrial ophthalmoplegia. Eur. J. Med. Res. 8: 485-491.
29. Jentjens, R.L., Shaw, C., Birtles, T., Waring, R.H., Harding, L.K., and Jeukendrup, A.E. 2005. Oxidation of combined ingestion of glucose and sucrose during exercise. Metabolism, 54: 610-618.
30. Jeukendrup, A.E., Thielen, J.J., Wagenmakers, A.J., Brouns, F., and Saris, W.H. 1998. Effect of medium-chain triacylglycerol and carbohydrate ingestion during exercise on substrate utilization and subsequent cycling performance. Am. J. Clin. Nutr. 67: 397-404.
31. Kazemi-Esfarjani, P., Skomorowska, E., Jensen, T.D., Haller, R.G., and Vissing, J. 2002. A nonischemic forearm exercise test for McArdle disease. Ann. Neurol. 52: 153-159.
32. Klopstock, T., Querner, V., Schmidt, F., Gekeler, F., Walter, M., Hartard, M., Henning, M., Gasser, T., Pongratz, D., Straube, A., Dieterich, M., and Muller-Felber, W. 2000. A placebo-controlled crossover trial of creatine in mitochondrial diseases. Neurology, 55: 1748-1751.
33. Komura, K., Hobbiebrunken, E., Wilichowski, E.K., and Hanefeld, P.A. 2003. Effectiveness of creatine monohydrate in mitochondrial encephalomyopathies. Pediatr. Neurol. 28: 53-58.
34. Kornblum, C., Schroder, R., Muller, K., Vorgerd, M., Eggers, J., Bogdanow, M., Papassotiropoulos, A., Fabian, K., Klockgether, T., and Zange, J. 2005. Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study. Eur. J. Neurol. 12: 300-309.
35. Kurtz, D.M., Rinaldo, P., Rhead, W.J., Tian, L., Millington, D.S., Vockley, J., Hamm, D.A., Brix, A.E., Lindsey, J.R., Pinkert, C.A., O'Brien, W.E., and Wood, P.A. 1998. Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation. Proc. Natl. Acad. Sci. U.S.A. 95: 15592-15597.
36. Lewis, S.F., Haller, R.G., Cook, J.D., and Blomqvist, C.G. 1984. Metabolic control of cardiac output response to exercise in McArdle's disease. J. Appl. Physiol. 57: 1749-1753.
37. Lloyd, S., Brocks, C., and Chatham, J.C. 2003. Differential modulation of glucose, lactate, and pyruvate oxidation by insulin and dichloroacetate in the rat heart. Am. J. Physiol. Heart Circ. Physiol. 285: H163-H172.
38. Matthews, P.M., Berkovic, S.P., Shoubridge, E.A., Andermann, F., Karpati, G., Carpenter, S., and Arnold, D.L. 1991. In vivo magnetic resonance spectroscopy of brain and muscle in a type of mitochondrial encephalomyopathy (MERRF). Ann. Neurol. 29: 435-438.
39. McKenzie, S., Phillips, S.M., Carter, S.L., Lowther, S., Gibala, M.J., and Tarnopolsky, M.A. 2000. Endurance exercise training attenuates leucine oxidation and BCOAD activation during exercise in humans. Am. J. Physiol. Endocrinol. Metab. 278: E580-E587.
40. Mori, M., Yamagata, T., Goto, T., Saito, S., and Momoi, M.Y. 2004. Dichloroacetate treatment for mitochondrial cytopathy: long-term effects in MELAS. Brain Dev. 26: 453-458.
41. Mortenseri, S.P., Dawson, E.A., Yoshiga, C.C., Dalsgaard, M.K., Damsgaard, R., Secher, N.H., and Gonzalez-Alonso, J. 2005. Limitations to systemic and locomotor limb muscle oxygen delivery and uptake during maximal exercise in humans. J. Physiol. 566: 273-285.
42. Norman, B., Sabina, R.L., and Jansson, E. 2001. Regulation of skeletal muscle ATP catabolism by AMPD1 genotype during sprint exercise in asymptomatic subjects. J. Appl. Physiol. 91: 258-264.
43. Orngreen, M.C., Ejstrup, R., and Vissing, J. 2003. Effect of diet on exercise tolerance in carnitine palmitoyltransferase II deficiency. Neurology, 61: 559-561.
44. Orngreen, M.C., Duno, M., Ejstrup, R., Christensen, E., Schwartz, M., Sacchetti, M., and Vissing, J. 2005. Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations. Ann. Neurol. 57: 60-66.
45. Pederson, B.A., Cheng, C., Wilson, W.A., and Roach, P.J. 2000. Regulation of glycogen synthase. Identification of residues involved in regulation by the allosteric ligand glucose-6-P and by phosphorylation. J. Biol. Chem. 275: 27753-27761.
46. Phoenix, J., Hopkins, P., Bartram, C., Beynon, R.J., Quinlivan, R.C., and Edwards, R.H. 1998. Effect of vitamin B6 supplementation in McArdle's disease: a strategic case study. Neuromuscul. Disord. 8: 210-212.
47. Riley, M., Nicholls, D.P., Nugent, A.M., Steele, I.C., Bell, N., Davies, P.M., Stanford, C.F., and Patterson, V.H. 1993. Respiratory gas exchange and metabolic responses during exercise in McArdle's disease. J. Appl. Physiol. 75: 745-754.
48. Sabina, R.L., Swain, J.L., Patten, B.M., Ashizawa, T., O'Brien, W.E., and Holmes, E.W. 1980. Disruption of the purine nucleotide cycle. A potential explanation for muscle dysfunction in myoadenylate deaminase deficiency. J. Clin. Invest. 66: 1419-1423.
49. Sabina, R.L., Swain, J.L., Olanow, C.W., Bradley, W.G., Fishbein, W.N., Dimauro, S., and Holmes, E.W. 1984. Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle. J. Clin. Invest. 73: 720-730.
50. Shoubridge, E.A., Johns, T., and Karpati, G. 1997. Complete restoration of a wild-type mtDNA genotype in regenerating muscle fibres in a patient with a tRNA point mutation and mitochondrial encephalomyopathy. Hum. Mol. Genet. 6: 2239-2242.
51. Shults, C.W., Oakes, D., Kieburtz, K., Beal, M.F., Haas, R., Plumb, S., Juncos, J.L., Nutt, J., Shoulson, I., Carter, J., Kompoliti, K., Perlmutter, J.S., Reich, S., Stern, M., Watts, R.L., Kurlan, R., Molho, E., Harrison, M., and Lew, M. 2002. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch. Neurol. 59: 1541-1550.
52. Sinkeler, S.P., Binkhorst, R.A., Joosten, E.M., Wevers, R.A., Coerwinkei, M.M., and Oei, T.L. 1987. AMP deaminase deficiency: study of the human skeletal muscle purine metabolism during ischaemic isometric exercise. Clin. Sci. (London), 72: 475-482.
53. Swain, J.L., Hines, J.J., Sabina, R.L., Harbury, O.L., and Holmes, E.W. 1984. Disruption of the purine nucleotide cycle by inhibition of adenylosuccinate lyase produces skeletal muscle dysfunction. J. Clin. Invest. 74: 1422-1427.
54. Taivassalo, T., Matthews, P.M., De Stefano, N., Sripathi, N., Genge, A., Karpati, G., and Arnold, D.L. 1996. Combined aerobic training and dichloroacetate improve exercise capacity and indices of aerobic metabolism in muscle cytochrome oxidase deficiency. Neurology, 47: 529-534.
55. Taivassalo, T., De Stefano, N., Argov, Z., Matthews, P.M., Chen, J., Genge, A., Karpati, G., and Arnold, D.L. 1998. Effects of aerobic training in patients with mitochondrial myopathies. Neurology, 50: 1055-1060.
56. Taivassalo, T., Fu, K., Johns, T., Arnold, D., Karpati, G., and Shoubridge, E.A. 1999. Gene shifting: a novel therapy for mitochondrial myopathy. Hum. Mol. Genet. 8: 1047-1052.
57. Taivassalo, T., Shoubridge, E.A., Chen, J., Kennaway, N.G., Dimauro, S., Arnold, D.L., and Haller, R.G. 2001. Aerobic conditioning in patients with mitochondrial myopathies: physiological, biochemical, and genetic effects. Ann. Neurol. 50: 133-141.
58. Taivassalo, T., Abbott, A., Wyrick, P., and Haller, R.G. 2002. Venous oxygen levels during aerobic forearm exercise: an index of impaired oxidative metabolism in mitochondrial myopathy. Ann. Neurol. 51: 38-44.
59. Taivassalo, T., Jensen, T.D., Kennaway, N., Dimauro, S., Vissing, J., and Haller, R.G. 2003. The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients. Brain. 126: 413-423.
60. Tamaoki, Y., Kimura, M., Hasegawa, Y., Iga, M., Inoue, M., and Yamaguchi, S. 2002. A survey of Japanese patients with mitochondrial fatty acid beta-oxidation and related disorders as detected from 1985 to 2000. Brain Dev. 24: 675-680.
61. Tarnopolsky, M.A., and Cupido, C. 2000. Caffeine potentiates low frequency skeletal muscle force in habitual and nonhabitual caffeine consumers. J. Appl. Physiol. 89: 1719-1724.
62. Tarnopolsky, M.A., and Parise, G. 1999. Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease. Muscle Nerve, 22: 1228-1233.
63. Tarnopolsky, M.A., Roy, B.D., and MacDonald, J.R. 1997. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve, 20: 1502-1509.
64. Tarnopolsky, M.A., Parise, G., Gibala, M.J., Graham, T.E., and Rush, J.W. 2001. Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans. J. Physiol. 533: 881-889.
65. Tarnopolsky, M.A., Stevens, L., MacDonald, J.R., Rodgriguez, C., Mahoney, D., Rush, J., and Maguire, J. 2003. Diagnostic utility of a modified forearm ischemic exercise test and technical issues relevant to exercise testing. Muscle Nerve, 27: 359-366.
66. Tarnopolsky, M.A., Simon, D.K., Roy, B.D., Chorneyko, K., Lowther, S.A., Johns, D.R., Sandhu, J.K., Li, Y., and Sikorska, M. 2004. Attenuation of free radical production and paracrystalline inclusions by creatine supplementation in a patient with a novel cytochrome b mutation. Muscle Nerve, 29: 537-547.
67. Tein, I. 1999. Neonatal metabolic myopathies. Semin. Perinatol. 23: 125-151.
68. Thorburn, D.R., Sugiana, C., Salemi, R., Kirby, D.M., Worgan, L., Ohtake, A., and Ryan, M.T. 2004. Biochemical and molecular diagnosis of mitochondrial respiratory chain disorders. Biochim. Biophys. Acta. 1659: 121-128.
69. Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J.N., Rovio, A.T., Bruder, C.E., Bohlooly, Y.M., Gidlof, S., Oldfors, A., Wimboni, R., Tornell, J., Jacobs, H.T., and Larsson, N.G. 2004. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature, 429: 417-423.
70. Tullson, P.C., Arabadjis, P.C., Rundell, K.W., and Terjung, R.L. 1996. IMP reamination to AMP in rat skeletal muscle fiber types. Am. J. Physiol. 270: C1067-C1074.
71. Turk, W.R., Heller, S.L., Norris, B.J., and Nemeth, P.M. 1990. Increased muscular beta-hydroxyacyl CoA dehydrogenase with McArdle's disease. Muscle Nerve, 13: 607-612.
72. Veksler, V.I., Kuznetsov, A.V., Anflous, K., Mateo, P., Van Deursen, J., Wieringa, B., and Ventura-Clapier, R. 1995. Muscle creatine kinase-deficient mice. II. Cardiac and skeletal muscles exhibit tissue-specific adaptation of the mitochondrial function. J. Biol. Chem. 270: 19921-19929.
73. Verzijl, H.T., Van Engelen, B.G., Luyten, J.A., Steenbergen, G.C., Van Denheuvel, L.P., Terlaak, H.J., Padberg, G.W., and Wevers, R.A. 1998. Genetic characteristics of myoadenylate deaminase deficiency. Ann. Neurol. 44: 140-143.
74. Vissing, J., and Haller, R.G. 2003. The effect of oral sucrose on exercise tolerance in patients with McArdle's disease. N. Engl. J. Med. 349: 2503-2509.
75. Vissing, J., Galbo, H., and Haller, R.G. 1996. Exercise fuel mobilization in mitochondrial myopathy: a metabolic dilemma. Ann. Neurol. 40: 655-662.
76. Vorgerd, M., Grehl, T., Jager, M., Muller, K., Freitag, G., Patzold, T., Bruns, N., Fabian, K., Tegenthoff, M., Mortier, W., Luttman, A., Zange, J., and Malin, J.P. 2000. Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial. Arch. Neurol. 57: 956-963.
77. Vorgerd, M., Zange, J., Kley, R., Grehl, T., Husing, A., Jager, M., Muller, K., Schroder, R., Mortier, W., Fabian, K., Malin, J.P., and Luttman, A. 2002. Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled crossover study. Arch. Neurol. 59: 97-101.
78. Watt, M.J., Southgate, R.J., Holmes, A.G., and Febbraio, M.A. 2004. Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) alpha and delta and PPAR coactivator 1alpha in human skeletal muscle, but not lipid regulatory genes. J. Mol. Endocrinol. 33: 533-544.
79. Winkler-Stuck, K., Wiedemann, F.R., Wallesch, C.W., and Kunz, W.S. 2004. Effect of coenzyme Q10 on the mitochondrial function of skin fibroblasts from Parkinson patients. J. Neurol. Sci. 220: 41-48.
80. Wolf, N.I., and Smeitink, J.A. 2002. Mitochondrial disorders: a proposal for consensus diagnostic criteria in infants and children. Neurology, 59: 1402-1405.
81. Xia, R., Webb, J.A., Gnall, L.L., Cutler, K., and Abramson, J.J. 2003. Skeletal muscle sarcoplasmic reticulum contains a NADH-dependent oxidase that generates superoxide. Am. J. Physiol. Cell Physiol. 285: C215-C221.
82. Zange, J., Grehl, T., Disselhorst-Klug, C., Rau, G., Muller, K., Schroder, R., Tegenthoff, M., Malin, J.P., and Vorgerd, M. 2003. Breakdown of adenine nucleotide pool in fatiguing skeletal muscle in McArdle's disease: a noninvasive 31P-MRS and EMG study. Muscle Nerve, 27: 728-736.